Dengue
Dengue is a mosquito-borne viral disease that affects millions of people worldwide. Caused by the Dengue virus, which belongs to the Flaviviridae family, the disease is transmitted primarily by Aedes aegypti and Aedes albopictus mosquitoes. Symptoms range from mild flu-like illness to severe, potentially life-threatening complications such as [[Dengue hemorrhagic fever]] and [[Dengue shock syndrome]]. With no specific treatment or vaccine available for all Dengue virus serotypes, prevention and control efforts remain critical to reducing its global burden.
Transmission and Causes
Dengue is transmitted through the bite of an infected mosquito, typically Aedes aegypti, which thrives in urban and semi-urban environments. The virus is maintained in a cycle between mosquitoes and humans, with mosquitoes becoming infectious after feeding on an infected person. Transmission is most common during the rainy season, when mosquito populations surge due to increased water accumulation. Human-to-human transmission does not occur, but the virus can be passed from an infected mother to her fetus during pregnancy or childbirth.
Symptoms and Complications
The clinical manifestations of Dengue vary widely. Mild cases typically present with sudden high fever, severe headache, joint and muscle pain, nausea, and a rash. However, approximately 1 in 20 Dengue infections progresses to severe disease, characterized by plasma leakage, fluid accumulation, and hemorrhagic manifestations. In severe cases, patients may develop shock, organ failure, or death if not promptly treated. Early recognition and medical care are essential to improving outcomes.
Global Impact and Statistics
Dengue is endemic in over 100 countries, with the majority of cases reported in Southeast Asia, the Western Pacific, and Latin America. The World Health Organization (WHO) estimates that about 390 million Dengue infections occur annually, with over 500,000 hospitalizations due to severe disease. Climate change, urbanization, and inadequate mosquito control measures are exacerbating the spread of Dengue, particularly in low- and middle-income countries.
Gender Differences in Impact
Research indicates that Dengue can affect men and women differently. Women may experience more severe symptoms or complications due to factors such as immune response variations, hormonal influences, and socioeconomic disparities in access to healthcare. For example, a study by the World Mosquito Program highlights that women are more likely to seek medical attention for Dengue symptoms, yet they may face greater barriers to treatment in certain regions. These disparities underscore the need for gender-sensitive approaches in Dengue prevention and management.
Prevention and Control
Preventing Dengue relies on reducing mosquito populations and minimizing human-mosquito contact. Strategies include eliminating standing water where mosquitoes breed, using insect repellents, and wearing protective clothing. Community-based initiatives, such as Aedes mosquito surveillance and public education campaigns, are also vital. While no universally effective vaccine exists, research into Dengue vaccines and novel vector control methods, such as genetically modified mosquitoes and Wolbachia-based interventions, continues to advance.
References
- World Mosquito Program: [1](https://www.worldmosquitoprogram.org/en/news-stories/stories/explainer-how-do-mosquito-borne-diseases-impact-women-differently)
This page contains information generated by Ollama. The information was reviewed, and may have been altered, by a human editor before being added to the Featured category. As of July 2026 information generated by AI is not subject to copyright and is thus in the public domain. This page is pending human review.